- Home
- MGIC vs KTTA Comparison
MGIC vs KTTA Comparison
Compare MGIC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGIC | KTTA |
|---|---|---|
| Founded | 1983 | 2020 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.3M | 5.3M |
| IPO Year | 1991 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MGIC | KTTA |
|---|---|---|
| Price | $26.89 | $1.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $18.00 | $3.00 |
| AVG Volume (30 Days) | 44.7K | ★ 17.5M |
| Earning Date | 11-18-2025 | 11-13-2025 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | ★ 16.15 | N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $603,216,000.00 | N/A |
| Revenue This Year | $12.87 | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $33.24 | ★ N/A |
| Revenue Growth | ★ 12.65 | N/A |
| 52 Week Low | $11.36 | $0.28 |
| 52 Week High | $27.44 | $3.85 |
Technical Indicators
Market Signals| Indicator | MGIC | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 59.44 |
| Support Level | $24.52 | $1.02 |
| Resistance Level | $27.44 | $1.21 |
| Average True Range (ATR) | 0.76 | 0.09 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 84.93 | 50.22 |
Price Performance
Historical ComparisonAbout MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).